港股異動 | 耐世特(1316.HK)續跌5% 去年利潤下降投行下調公司評級
格隆匯3月19日丨耐世特(1316.HK)續跌5.26%,報10.8港元,最新總市值270.93億,近兩交易日累計跌逾10%。公司17日公吿稱,截至2020年12月31日止12個月集團收入30.32億美元,同比減少15.20%;公司權益持有人應占利潤1.17億美元,同比減少49.77%;擬派末期息每股0.0094美元。大和認為,受2020年疫情的負面影響,公司收入同比跌15%符合預期,由於利潤率疲弱,淨利潤下降50%遜預期,同時全球芯片供應短缺的因素,將今年的收入預測削減10%和淨利潤預測削減16%。將公司評級由跑贏大市降至持有,目標價由15港元降至12港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.